Jan 31 (Reuters) - Starpharma Holdings Ltd:
* RECEIVED REGULATORY AND ETHICS APPROVAL TO COMMENCE ITS PHASE-1/2 CLINICAL TRIAL DOE DEP CABAZITAXEL‍​ Source text for Eikon: Further company coverage:
 